Therefore, despite the slight heterogeneity of the included studies in the analysis of the impact of mutant PIK3CA on the response and survival outcomes of NSCLC patients, our result would be consolidated by increasing sample size. Here, PIK3CA is linked to non-small cell lung carcinoma.